Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2006-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_133b3c4740df04a1c8181e90f9659218 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3319ab73b6794e99f2c82a7d68c66e61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4cc9fcca67624a76cc9d466b46ab2d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920178b927508ce2d05b3b6e3a7c6800 |
publicationDate |
2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101321758-A |
titleOfInvention |
Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease |
abstract |
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023138676-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110092788-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110092788-B |
priorityDate |
2005-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |